13F HOLDINGS REPORT
Lion Point Capital, LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001013594-24-000659
Total Value
$54.9M
Positions
27
Other Managers
0
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ISHARES TR | 464287655 | 82,500 | $16.7M | 30.51% |
| 2 | ARDELYX INC | ARDX | 856,667 | $6.3M | 11.57% |
| 3 | INSMED INC | INSM | 70,335 | $4.7M | 8.59% |
| 4 | SPDR SER TR | 78464A870 | 50,000 | $4.6M | 8.45% |
| 5 | MILESTONE PHARMACEUTICALS IN | MIST | 2,340,207 | $3.1M | 5.63% |
| 6 | GERON CORP | GERN | 630,000 | $2.7M | 4.87% |
| 7 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 2,114,827 | $2.5M | 4.51% |
| 8 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 104,691 | $2.0M | 3.56% |
| 9 | MIRUM PHARMACEUTICALS INC | MIRM | 45,000 | $1.5M | 2.80% |
| 10 | SYNDAX PHARMACEUTICALS INC | SNDX | 65,000 | $1.3M | 2.43% |
| 11 | BRIDGEBIO PHARMA INC | BBIO | 49,000 | $1.2M | 2.26% |
| 12 | AVADEL PHARMACEUTICALS PLC | G29687103 | 82,500 | $1.2M | 2.11% |
| 13 | NEUROCRINE BIOSCIENCES INC | NBIX | 8,350 | $1.1M | 2.10% |
| 14 | FENNEC PHARMACEUTICALS INC | FENC | 170,000 | $1.0M | 1.89% |
| 15 | MINERALYS THERAPEUTICS INC | MLYS | 79,000 | $924,300 | 1.69% |
| 16 | ENPHYS ACQUISITION CORP | G3167L109 | 78,125 | $857,813 | 1.56% |
| 17 | JASPER THERAPEUTICS INC | JSPRW | 32,000 | $726,400 | 1.32% |
| 18 | BLUEBIRD BIO INC | 09609G100 | 678,256 | $667,540 | 1.22% |
| 19 | BURGERFI INTERNATIONAL INC | 12122L101 | 2,745,938 | $557,425 | 1.02% |
| 20 | REGENXBIO INC | RGNX | 36,250 | $424,125 | 0.77% |
| 21 | SERES THERAPEUTICS INC | MCRB | 340,761 | $246,643 | 0.45% |
| 22 | LUMOS PHARMA INC | 55028X109 | 90,794 | $210,642 | 0.38% |
| 23 | MICROSOFT CORP | MSFT | 100 | $44,695 | 0.08% |
| 24 | SPRUCE BIOSCIENCES INC | SPRB | 75,000 | $38,828 | 0.07% |
| 25 | BURGERFI INTERNATIONAL INC | 12122L119 | 2,083,438 | $26,251 | 0.05% |
| 26 | BATTALION OIL CORP | BATL | 7,423 | $24,793 | 0.05% |
| 27 | ALPHABET INC | GOOG | 100 | $18,342 | 0.03% |